Sabby Management, LLC Soleno Therapeutics Inc Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$1.35 - $2.68 $715,393 - $1.42 Million	-529,921 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$1.55 - $2.3 $349,356 - $518,399	-225,391 Reduced 29.84%	529,921 $906,000
Q3 2018 Nov 14, 2018	SELL	$1.95 - $3.07 $59,753 - $94,074	-30,643 Reduced 3.9%	755,312 $1.63 Million
Q2 2018 Aug 14, 2018	SELL	$1.56 - $3.1 $205,732 - $408,828	-131,880 Reduced 14.37%	785,955 $1.84 Million
Q1 2018 May 15, 2018	BUY	$1.56 - $2.12 $4,266 - $5,798	2,735 Added 0.3%	917,835 $1.66 Million
Q4 2017 Feb 14, 2018	BUY	$1.39 - $2.73 $1.27 Million - $2.5 Million	915,100	915,100 $1.65 Million

550K

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $454M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.